Skip to content
RxMonitor home

Medication

Miebo

DIN 02551403 · Bausch & Lomb Inc

What it is

Active ingredients
Form and route
Solution · Ophthalmic
Schedule
PRESCRIPTION
Authorised since
2024-12-18

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

Products with the same active ingredient

No other medication authorised in Canada shares this active ingredient.

Health Canada groups products by their active ingredients. No other marketed product shares this one’s group, which usually means it is still the only authorised version — not that alternatives were hidden or missed.

How it is classified

Anatomical main group
Sensory organs
ATC code
S01XA20

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of S01XA20, see the WHO ATC/DDD Index.

Recalls and safety alerts

Recall matching is not available yet.

RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.

Search Health Canada recalls for Miebo

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.